Royal Bank of Canada’s Purple Biotech PPBT Stock Holding History

Royal Bank of Canada’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Sell	10 -1	-9%	-$5	﹤0.01%	7554
2025 Q4	$0	Hold	11	–	–	﹤0.01%	7522
2025 Q3	$0	Hold	11	–	–	﹤0.01%	7424
2025 Q2	$0	Hold	11	–	–	﹤0.01%	7270
2025 Q1	$0	Hold	11	–	–	﹤0.01%	7149
2024 Q4	$1K	Hold	11	–	–	﹤0.01%	6813
2024 Q3	$1K	Hold	11	–	–	﹤0.01%	6736
2024 Q2	$1K	Hold	11	–	–	﹤0.01%	6880
2024 Q1	$1K	Buy	+11	New	+$1.58K	﹤0.01%	6843
2023 Q4	–	Sell	-1	Closed	-$221	–	7476
2023 Q3	$0	Hold	1	–	–	﹤0.01%	7451
2023 Q2	$0	Hold	1	–	–	﹤0.01%	7561
2023 Q1	$0	Hold	1	–	–	﹤0.01%	7384
2022 Q4	$0	Hold	1	–	–	﹤0.01%	7603
2022 Q3	$0	Hold	1	–	–	﹤0.01%	7760
2022 Q2	$0	Hold	1	–	–	﹤0.01%	7636
2022 Q1	$0	Buy	+1	New	+$645	﹤0.01%	7947

Other funds holding PPBT

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SmartHarvest Portfolios Poulsbo, Washington $309M AUM

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Royal Bank of Canada's PPBT Position: Q1 2026 in Review

Royal Bank of Canada reduced its Purple Biotech (PPBT) stake by 9.1% in Q1 2026, selling an estimated $5 and leaving 10 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7554.

Royal Bank of Canada first reported a position in PPBT in Q1 2022 and has held it in 16 quarters since. The position peaked at $1K in Q4 2024. 15 funds tracked by Wall St. Rank hold PPBT as of Q1 2026.

Royal Bank of Canada held 10 shares of Purple Biotech worth $0 as of Q1 2026.
Royal Bank of Canada sold 1 Purple Biotech share in Q1 2026, an estimated $5.
Purple Biotech made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7554 holding.
Royal Bank of Canada first reported a position in Purple Biotech in Q1 2022 and has held it in 16 quarters since.
Royal Bank of Canada's Purple Biotech position peaked at $1K in Q4 2024.
15 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.